The Readout
Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Here’s our web archive of the free email newsletter delivered daily, Monday through Friday.
Latest
STAT Plus: The Fed cut rates and biotech stocks… didn’t do much
STAT Plus: Bernie Sanders keeps the heat on Novo’s high prices
STAT Plus: FDA formalizes protocol for international cancer trials
STAT Plus: The essential biotech updates of the day
STAT Plus: Can GLP-1 drugs help with type 1 diabetes?
STAT Plus: Moderna cuts spending, and Sarepta’s ‘curse’ on Califf
STAT Plus: Eli Lilly releases new data on weekly insulin
All Coverage
